MODYvs type 1 diabetes Understanding the role of c-peptide in MODY (Maturity-Onset Diabetes of the Young) is crucial for accurate diagnosis and effective management of this genetic form of diabetesGenetic testing for monogenic diabetes (R141 and R143) will only be performed on patients confirmed to have diabetes by laboratory blood glucose or HbA1c.. While often mistaken for type 1 diabetes, MODY is characterized by distinct features, and c-peptide levels serve as a vital biomarker in differentiating it from other diabetes types. Specifically, a level of fasting c-peptide measured at the time of diabetes manifestation can be highly beneficial in distinguishing MODY from type 1 diabetes, as c-peptide remains in the normal range in many MODY patients, indicating continued insulin production by the pancreas.
C-peptide is a byproduct of insulin production, and its levels in the blood or urine directly reflect how much insulin the pancreas is synthesizing. In individuals with MODY, the genetic defect affects insulin production or function, but crucially, the beta cells in the pancreas often remain functional, leading to detectable c-peptide levels. This is a key distinction from type 1 diabetes, an autoimmune condition where the body attacks and destroys insulin-producing beta cells, resulting in very low or undetectable c-peptide levelsUtility of Fasting C-Peptide for the Diagnostic Differentiation ....
The c-peptide level is a measure of how much insulin an individual is producing themselves.作者：P Johnston—C-peptide level is a measure of how much insulin an individual is producing themselves(Diabetes Genes, 2025). A low level is more suggestive of ... For those with MODY, this endogenous insulin production can persist for years, a characteristic known as c-peptide persistence. This persistence is an important clinical feature of MODY and can be assessed through blood tests. In some cases, even when insulin production is impaired, the pancreas may still produce enough insulin to maintain detectable c-peptide levels, especially with certain subtypes of MODY.作者：YN Lee·2021·被引用次数：14—There is also a role forurinary C-peptide creatinine ratioas a practical outpatient tool in discriminating between HNF1α/HNF4α MODY (>0.2 nmol/mmol) and T1D ...
The ability of the c-peptide test to assess endogenous insulin production makes it an indispensable tool for differentiating MODY from other forms of diabetes.When to consider a diagnosis of MODY at the presentation ...
* MODY vs. Type 1 Diabetes: As mentioned, type 1 diabetes is characterized by the destruction of beta cells, leading to a severe deficiency in insulin and consequently, low c-peptide levels作者：R Kant·2022·被引用次数：42—In healthy people, fastingC-peptidelevels range from 0.9 to 1.8 ng per mL (0.3 to 0.6 nmol per L) and increase to 3 to 9 ng per mL (1 to 3 nmol per L) after .... In contrast, many individuals with MODY will have normal or near-normal fasting c-peptide levels, particularly at diagnosis. This is why the c-peptide is a useful marker for distinguishing MODY patients from those with autoimmune type 1 diabetes. While some MODY subtypes might eventually lead to reduced insulin secretion, the initial presentation often differs significantly from type 1 diabetes based on c-peptide.Uncommon forms of diabetes
* MODY vs. Type 2 Diabetes: Type 2 diabetes typically develops later in life and is associated with insulin resistance, though the pancreas initially compensates by producing more insulin, leading to higher c-peptide levelsDiabetes. As type 2 diabetes progresses, insulin production may decline. Distinguishing MODY from type 2 diabetes can sometimes be challenging, especially in individuals diagnosed at a younger age.COMPARISON OF C-PEPTIDE LEVELS IN MONOGENIC ... However, genetic testing is the definitive method for diagnosing MODY, and c-peptide levels can provide supporting evidence.2025年10月13日—C-peptidetest: This test measures how much insulin your body makes. People withMODYstill make some insulin. Genetic tests: These tests ... In some instances, individuals with MODY might be misdiagnosed with type 2 diabetes if their c-peptide levels are not critically low, highlighting the importance of considering genetic factors.
Diagnosing MODY often involves a combination of clinical suspicion, family history, immunological testing for autoantibodies, and genetic testing作者：R Kant·2022·被引用次数：42—In healthy people, fastingC-peptidelevels range from 0.9 to 1.8 ng per mL (0.3 to 0.6 nmol per L) and increase to 3 to 9 ng per mL (1 to 3 nmol per L) after .... C-peptide testing plays a crucial role in the initial workup.
* Fasting C-Peptide: Measuring fasting c-peptide levels is a common starting pointMaturity-Onset Diabetes of the Young: Rapid Evidence .... Normal or elevated levels in a young individual with diabetes, especially in the absence of autoantibodies, should raise suspicion for MODY“MODY” is a collection of very specific genetic variants that can affect a number of things about insulin. At least one subtype affects the ....
* Postprandial C-Peptide: In some cases, a c-peptide response to a glucose load can provide further insight into beta-cell function.
* Urinary C-Peptide: For practical outpatient assessment, the urinary c-peptide creatinine ratio can be a useful tool. This non-invasive test can help differentiate between certain MODY subtypes and type 1 diabetes, offering a convenient alternative to blood draws.
The blood or urine tested for c-peptide provides essential information about the body's insulin-making capacity. While c-peptide testing is not a definitive diagnostic tool for MODY on its own, it is an indispensable part of the diagnostic pathway, guiding clinicians toward genetic testing when MODY is suspectedDiagnostic Inertia in Identifying Maturity-Onset Diabetes of ....
While the primary role of c-peptide in MODY is diagnostic, its levels can also offer insights into the progression of the condition and the effectiveness of treatment. In MODY, the focus is often on preserving beta-cell function and managing hyperglycemia. For certain MODY subtypes, oral medications may be effective, and monitoring c-peptide levels can help assess the continued capacity of the pancreas to produce insulin. In cases where insulin secretion declines significantly over time, c-peptide levels would reflect this change, potentially indicating a need for adjustments in treatment strategy.
The c-peptide test is a vital component in the diagnostic journey for MODY2011年7月16日—The insulin andC-peptidelevels can become so low in someMODYpatients ...C-peptidelevels,MODYshould be suspected. Under these .... By reflecting endogenous insulin production, it helps clinicians differentiate MODY from type 1 and type 2 diabetes, guiding further investigation with genetic testing. The persistence of c-peptide in many MODY patients underscores the genetic basis of this condition and highlights the importance of preserving remaining beta-cell function.Biomarkers: Tools for Discriminating MODY from Other... Understanding the nuances of c-peptide levels in the context of MODY empowers healthcare providers to make accurate diagnoses and tailor treatment plans effectively for individuals affected by this complex form of diabetes.
Join the newsletter to receive news, updates, new products and freebies in your inbox.